Stockscreener 앱 받기
338.72
0.14%
0.46
시간 외 거래:
338.72
전일 마감가:
$338.26
열려 있는:
$338.05
하루 거래량:
778.06K
Relative Volume:
0.86
시가총액:
$13.29B
수익:
$1.24B
순이익/손실:
$42.23M
주가수익비율:
319.55
EPS:
1.06
순현금흐름:
$150.33M
1주 성능:
-0.96%
1개월 성능:
+6.03%
6개월 성능:
+36.28%
1년 성능:
+26.83%
1일 변동 폭
$338.05
$340.34
1주일 범위
$337.63
$344.07
52주 변동 폭
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
명칭
Penumbra Inc
전화
(510) 995-2486
주소
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
338.72 | 13.27B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-11-18 | 개시 | Wells Fargo | Underweight |
| 2025-10-08 | 업그레이드 | Needham | Hold → Buy |
| 2025-09-02 | 개시 | Evercore ISI | Outperform |
| 2025-03-14 | 개시 | BofA Securities | Buy |
| 2025-01-21 | 개시 | UBS | Buy |
| 2024-12-17 | 개시 | Oppenheimer | Outperform |
| 2024-12-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | 개시 | Stifel | Buy |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-31 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-09-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-03-29 | 다운그레이드 | Needham | Buy → Hold |
| 2023-01-30 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-09 | 업그레이드 | Needham | Hold → Buy |
| 2022-07-18 | 개시 | RBC Capital Mkts | Outperform |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-03-08 | 개시 | Needham | Hold |
| 2021-09-16 | 개시 | Truist | Buy |
| 2021-06-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-12-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-07 | 재개 | Canaccord Genuity | Buy |
| 2020-09-29 | 개시 | BTIG Research | Buy |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-05-30 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-05-21 | 개시 | William Blair | Outperform |
| 2018-10-29 | 재개 | BofA/Merrill | Buy |
| 2018-10-08 | 개시 | RBC Capital Mkts | Outperform |
| 2018-02-21 | 개시 | William Blair | Outperform |
| 2018-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-13 | 개시 | Wells Fargo | Outperform |
모두보기
Penumbra Inc 주식(PEN)의 최신 뉴스
The Truth About Penumbra Inc: Why Wall Street Is Watching While TikTok Sleeps On It - AD HOC NEWS
Wesbanco Bank Inc. Purchases New Position in Penumbra, Inc. $PEN - MarketBeat
Penumbra (PEN) Projected to Post Earnings on Tuesday - MarketBeat
Has Penumbra (PEN) Risen Too Far After Strong One Year Share Price Gain? - Yahoo Finance
Penumbra Sale To Boston Scientific Recasts Growth Story For Investors - Sahm
Penumbra, Inc. $PEN Stock Holdings Lowered by Principal Financial Group Inc. - MarketBeat
Penumbra (PEN) Reported Revenue Growth of 16.9% in Q4 - Insider Monkey
AGF Management Ltd. Makes New $3.14 Million Investment in Penumbra, Inc. $PEN - MarketBeat
Hantz Financial Services Inc. Lowers Position in Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. (PEN): A Bull Case Theory - Finviz
Boston Scientific earnings on deck after Q3 miss, Penumbra deal By Investing.com - Investing.com Canada
AI Stocks: Is Penumbra Inc on track to beat earningsJuly 2025 Momentum & Risk Managed Investment Signals - baoquankhu1.vn
Halper Sadeh LLC Reminds Shareholders of RAPT, PEN, CVGW, FONR of the Firm’s Investigations - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Thrivent Financial for Lutherans Purchases 44,185 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. $PEN Shares Acquired by New York State Common Retirement Fund - MarketBeat
Penumbra Acquisition Finalized in Multi-Billion Dollar Deal with Boston Scientific - AD HOC NEWS
Boston Scientific Reshapes Portfolio With Nalu And Penumbra Neuro Deals - Yahoo Finance
Penumbra, Inc. (NYSE:PEN) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Y Intercept Hong Kong Ltd Cuts Position in Penumbra, Inc. $PEN - MarketBeat
Boston Scientific (BSX) garnering bullish views amid Penumbra acquisition - MSN
Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings - TechStock²
Boston Scientific (BSX) Garnering Bullish Views Amid Penumbra Acquisition - Yahoo Finance
Hussman Strategic Advisors Inc. Makes New Investment in Penumbra, Inc. $PEN - MarketBeat
Boston Scientific to acquire Alameda-based Penumbra for $14.5 billion - MSN
Halper Sadeh LLC Investigates Penumbra and RAPT Transactions - intellectia.ai
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants - FinancialContent
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA - Sahm
Halper Sadeh Investigates Potential Violations by Penumbra, Amicus, DigitalBridge, and Flushing Financial - intellectia.ai
Strs Ohio Cuts Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
Boston Scientific Buyout Caps Penumbra Upside And Shifts Investor Focus - Sahm
EFG Asset Management North America Corp. Acquires 3,631 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra launches next-gen Lightning Flash 3.0 thrombectomy system - MassDevice
Fed Meeting: Is Penumbra Inc likely to announce a buybackJuly 2025 Rallies & Daily Profit Focused Stock Screening - baoquankhu1.vn
Boston Scientific Penumbra Deal Recasts Growth Prospects In Thrombectomy And Neurovascular - Sahm
Baillie Gifford & Co. Sells 13,581 Shares of Penumbra, Inc. $PEN - MarketBeat
Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. - Barron's
Price Over Earnings Overview: Penumbra - Benzinga
Oppenheimer Questions Valuation of Boston Scientific’s $14.5 Billion Penumbra Deal - Yahoo Finance
Boston Scientific announces agreement to acquire Penumbra, Inc. - Quantisnow
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—PEN, DBRG, FFIC, and FOLD - GlobeNewswire
Halper Sadeh Investigates Potential Securities Violations by Penumbra, Exact Sciences, DigitalBridge, and Flushing Financial - Intellectia AI
Boston Sci secures CE mark for Embold system - BioWorld MedTech
Penumbra (NYSE:PEN) Sets New 52-Week HighWhat's Next? - MarketBeat
Penumbra Inc stock hits all-time high at 352.3 USD By Investing.com - Investing.com Nigeria
Boston Scientific (BSX) to acquire Penumbra in $14.5B neurovascular push - Stock Titan
Halper Sadeh Investigates Penumbra and Others for Potential Violations - Intellectia AI
Penumbra (PEN) Sees Downgrade with Revised Price Target from Can - GuruFocus
Risk Report: Is ALTGs ROE strong enoughJuly 2025 Big Picture & Weekly Setup with High ROI Potential - baoquankhu1.vn
Boston Scientific to acquire Penumbra (NYSE: PEN) in $14.5B deal - Stock Titan
3 takeaways from Boston Scientific’s $14.5B Penumbra deal - MedTech Dive
Penumbra Inc (PEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
0.31%
자본화:
|
볼륨(24시간):